Detalhe da pesquisa
1.
Correction: All-purpose nanostrategy based on dose deposition enhancement, cell cycle arrest, DNA damage, and ROS production as prostate cancer radiosensitizer for potential clinical translation.
Nanoscale
; 14(17): 6670, 2022 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35466988
2.
All-purpose nanostrategy based on dose deposition enhancement, cell cycle arrest, DNA damage, and ROS production as prostate cancer radiosensitizer for potential clinical translation.
Nanoscale
; 13(34): 14525-14537, 2021 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34473816